Skip to main content

Tempus: Christopher Mason

Christopher Mason is planning to take a leave of absence from his post as associate professor in the Department of Physiology and Biophysics at Weill Cornell Medicine to work on COVID-19 testing, including at Tempus, Biotia, and labs in Wisconsin and New York City. Chicago-based Tempus said in June that Mason has joined the firm as VP of emerging genome technology. He holds a PhD in genetics from Yale University and a dual BS degree in genetics and biochemistry from the University of Wisconsin-Madison.